Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist

Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist

Cancer cachexia is defined as a multifactorial syndrome of involuntary weight loss characterized by an ongoing loss of skeletal muscle mass and progressive functional impairment. It is postulated that cardiac dysfunction/atrophy parallels skeletal muscle atrophy in cancer cachexia. Cardiotoxic chemo...

Full description

Bibliographic Details
Main Authors:	Kazemi-Bajestani, Seyyed M. R., Becher, Harald, Fassbender, Konrad, Chu, Quincy, Baracos, Vickie E.
Format:	Online
Language:	English
Published:	Springer Berlin Heidelberg 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053562/

Similar Items

Concurrent depletion of skeletal muscle, fat, and left ventricular mass in patients with cirrhosis of the liver
by: Kazemi‐Bajestani, Seyyed Mohammad Reza, et al.
Published: (2015)

Pitfalls in defining and quantifying cachexia
by: Baracos, Vickie E.
Published: (2011)

Altered cancer cell metabolism and cachexia: Calculating the energetic cost of cancer
by: Friesen, Douglas, et al.
Published: (2014)

Emerging Biomarkers in Heart Failure and Cardiac Cachexia
by: Loncar, Goran, et al.
Published: (2014)

Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia
by: Friesen, Douglas E., et al.
Published: (2015)

Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges
by: Kazemi-Bajestani, Seyyed M. R., et al.
Published: (2012)

Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure
by: Habedank, Dirk, et al.
Published: (2013)

An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada
by: Guttridge, Denis, et al.
Published: (2014)

Concurrent muscle and bone deterioration in a murine model of cancer cachexia
by: Choi, EunHi, et al.
Published: (2013)

Current Status of Publications of Cardiovascular Interventions in Iran; a PubMed-Based Study
by: Ebrahimi, Mahmoud, et al.
Published: (2012)

Differences in routine laboratory parameters related to cachexia between patients with hematological diseases and patients with solid tumors or heart failure – is there only one cachexia?
by: Letilovic, Tomislav, et al.
Published: (2013)

A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart
by: Sala, Valentina, et al.
Published: (2016)

Cachexia in heart disease: highlights from the ESC 2010
by: Kung, Thomas, et al.
Published: (2011)

P-selectin genotype is associated with the development of cancer cachexia
by: Tan, Benjamin H L, et al.
Published: (2012)

The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
by: Vagnildhaug, Ola Magne, et al.
Published: (2017)

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
by: von Haehling, Stephan, et al.
Published: (2010)

Lipid Clinics Are Urgently Required in the Iranian Public Health System
by: Ghayour-Mobarhan, Majid, et al.
Published: (2010)

Concept of Atherosclerosis Velocity: Is It a Better Measure of Cardiovascular Risk?
by: Kazemi-Bajestani, Seyyed Mohammad Reza, et al.
Published: (2013)

Cancer cachexia
by: Dhanapal, Raghu, et al.
Published: (2011)

Cancer cachexia.
by: Tisdale, M. J.
Published: (1991)

Ghrelin for cachexia
by: Akamizu, Takashi, et al.
Published: (2010)

Cancer cachexia
by: Martignoni, Marcus E, et al.
Published: (2003)

Splenic Cachexia
Published: (1904)

Inflammation in Cachexia
by: Seelaender, M., et al.
Published: (2015)

Request for regulatory guidance for cancer cachexia intervention trials
by: Fearon, KCH, et al.
Published: (2015)

Formoterol in the treatment of experimental cancer cachexia: effects on heart function
by: Toledo, Míriam, et al.
Published: (2014)

Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference
by: Ebner, Nicole, et al.
Published: (2012)

Experimental Heart Failure Models and Their Pathophysiological Characterization
by: Becher, Peter Moritz, et al.
Published: (2016)

The Apelin-APJ System in the Evolution of Heart Failure
by: GOIDESCU, CERASELA MIHAELA, et al.
Published: (2015)

The Evolution of the Stem Cell Theory for Heart Failure
by: Silvestre, Jean-Sébastien, et al.
Published: (2015)

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure
by: Tompkins, Bryon, et al.
Published: (2015)

Lipid metabolism in cancer cachexia.
by: Mulligan, H. D., et al.
Published: (1992)

Leptin in Anorexia and Cachexia Syndrome
by: Engineer, Diana R., et al.
Published: (2012)

Selecting for predisposition to cancer cachexia
by: Gioulbasanis, Ioannis, et al.
Published: (2012)

Cancer cachexia—pathophysiology and management
by: Suzuki, Hajime, et al.
Published: (2013)

Psychosocial impact of cancer cachexia
by: Hopkinson, Jane B.
Published: (2014)

mTOR and Tumor Cachexia
by: Adrian P. Duval, et al.
Published: (2018-07-01)

Special Issue on Cancer Cachexia
by: Susan Mcclement
Published: (2018-01-01)

Cachexia in cancer: what is in the definition?
by: Vanhoutte, Greetje, et al.
Published: (2016)

Beneficial bacteria inhibit cachexia
by: Varian, Bernard J., et al.
Published: (2016)